Cover Image

VMolplex Ltd.:產品平台分析

Molplex Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 340847
出版日期 內容資訊 英文 23 Pages
Back to Top
VMolplex Ltd.:產品平台分析 Molplex Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 23 Pages



VMolplex Ltd.是開發、發現癌症、感染疾病、自體免疫疾病、發炎性疾病等治療藥的製藥企業。

本報告提供VMolplex Ltd.的醫藥品開發平台的現狀及各開發階段比較分析與藥物簡介,提供您給藥途徑,各分子類型的藥物評估,暫停中的開發計劃等資訊。

Molplex Ltd.的基本資料

  • 概要
  • 主要資訊
  • 企業資料

Molplex Ltd.:R&D概要

  • 主要的治療範圍

Molplex Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Molplex Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

Molplex Ltd.:藥物簡介

  • 傳染性單核症治療用小分子
  • 自體免疫疾病治療用小分子
  • 骨病變治療用小分子
  • 登革熱治療用小分子
  • 瀰漫性大細胞型B細胞淋巴瘤治療用小分子
  • 革蘭氏陽性細菌感染治療用小分子
  • 頭頸癌復發性鱗狀細胞癌治療用小分子
  • 腫瘤治療用小分子

Molplex Ltd.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Molplex Ltd.:暫停中的計劃

Molplex Ltd.:總公司和子公司的所在地


Product Code: GMDHC07436CDB


Global Markets Direct's, 'Molplex Ltd. - Product Pipeline Review - 2015', provides an overview of the Molplex Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molplex Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Molplex Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Molplex Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Molplex Ltd.'s pipeline products

Reasons to buy

  • Evaluate Molplex Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Molplex Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Molplex Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Molplex Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molplex Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Molplex Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Molplex Ltd. Snapshot
    • Molplex Ltd. Overview
    • Key Information
    • Key Facts
  • Molplex Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Molplex Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Molplex Ltd. - Pipeline Products Glance
    • Molplex Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Molplex Ltd. - Drug Profiles
    • Small Molecule for Infectious Mononucleosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Autoimmune Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Bone Lesions
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Dengue
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Diffuse Large B Cell Lymphoma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Gram-Positive Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Head and Neck Cancer Squamous Cell Carcinoma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Molplex Ltd. - Pipeline Analysis
  • Molplex Ltd. - Pipeline Products by Route of Administration
  • Molplex Ltd. - Pipeline Products by Molecule Type
  • Molplex Ltd. - Dormant Projects
  • Molplex Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Molplex Ltd., Key Information
  • Molplex Ltd., Key Facts
  • Molplex Ltd. - Pipeline by Indication, 2015
  • Molplex Ltd. - Pipeline by Stage of Development, 2015
  • Molplex Ltd. - Monotherapy Products in Pipeline, 2015
  • Molplex Ltd. - Discovery, 2015
  • Molplex Ltd. - Pipeline by Route of Administration, 2015
  • Molplex Ltd. - Pipeline by Molecule Type, 2015
  • Molplex Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Molplex Ltd. - Pipeline by Top 10 Indication, 2015
Back to Top